A 2-year open-label study of botulinum toxin type B in botulinum toxin type A resistant/responsive cervical dystonia patients (AN072-401 EU/CD)
✍ Scribed by Moore Peter; Ferreira Joaquim; Pappert Eric
- Book ID
- 116922115
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 40 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0041-0101
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Botulinum toxin (BTX) injection is considered the treatment of choice for patients with cervical dystonia (torticollis). We conducted a pilot, open‐label, dose‐escalation study with BTX type B in 12 patients who no longer responded clinically to injections with BTX type A. At the doses
## Abstract Efficacy of botulinum toxin type B (BoNT B) for the treatment of type A‐resistant (AR) and non‐A‐resistant (NAR) cervical dystonia (CD) has been demonstrated in several single injection studies. There is little data available on long‐term therapy with repeated injection sessions and it